Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mark H. Yazer, Gleb Panko, John B. Holcomb, Alesia Kaplan, Christine Leeper, Jansen N. Seheult, Darrell J. Triulzi & Philip C. Spinella. (2023) Not as “D”eadly as once thought – the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma. Hematology 28:1.
Read now
Read now
Mark H. Yazer, Philip C. Spinella, Eric A. Bank, Jeremy W. Cannon, Nancy M. Dunbar, John B. Holcomb, Bryon P. Jackson, Donald Jenkins, Michael Levy, Paul E. Pepe, Jason L. Sperry, James R. Stubbs & Christopher J. Winckler. (2022) THOR-AABB Working Party Recommendations for a Prehospital Blood Product Transfusion Program. Prehospital Emergency Care 26:6, pages 863-875.
Read now
Read now
Articles from other publishers (11)
Jennifer Andrews, Cassandra D. Josephson, Pampee Young, Philip C. Spinella & Mark H. Yazer. (2023)
Weighing the risk of hemolytic disease of the newborn versus the benefits of using of
RhD
‐positive blood products in trauma
. Transfusion 63:S3.
Crossref
Crossref
Jason B Brill, Krislynn M Mueck, Brian Tang, Mariela Sandoval, Madeline E Cotton, C Cameron McCoy & Bryan A Cotton. (2022) Is Low-Titer Group O Whole Blood Truly a Universal Blood Product?. Journal of the American College of Surgeons 236:3, pages 506-513.
Crossref
Crossref
Mark H. Yazer, José R. Díaz‐Valdés, Darrell J. Triulzi & Andrew P. Cap. (2022)
Wider perspectives: It’s a changing world—The use of
ABO
‐incompatible plasma for resuscitating massively bleeding patients
. British Journal of Haematology 200:3, pages 291-296.
Crossref
Crossref
Trisha E. Wong, Katie Wiggins-Dohlvik, Cassandra D. Josephson & Kathleen K. Nicol. (2023) Blood banking considerations in pediatric trauma. Journal of Trauma and Acute Care Surgery 94:1S, pages S41-S49.
Crossref
Crossref
Mark H. Yazer, Alain Corcos, Jason L Sperry, Darrell J. Triulzi & Christine Leeper. (2022) Receipt of at least 4 units of low titer group O whole blood with titer <100 does not lead to hemolysis in adult trauma patients. Transfusion 62:S1.
Crossref
Crossref
Dana Meshkin, Mark H. Yazer, Nancy M. Dunbar, Philip C. Spinella & Christine M. Leeper. (2022) Low titer Group O whole blood utilization in pediatric trauma resuscitation: A National Survey. Transfusion 62:S1.
Crossref
Crossref
Joar Sivertsen, Tor Hervig, Geir Strandenes, Einar K. Kristoffersen, Hanne Braathen & Torunn O. Apelseth. (2022)
In vitro quality and hemostatic function of cold‐stored
CPDA
‐1 whole blood after repeated transient exposure to 28°C storage temperature
. Transfusion 62:S1.
Crossref
Crossref
Valery J. Kogler & Moritz Stolla. (2022) There and back again: the once and current developments in donor-derived platelet products for hemostatic therapy. Blood 139:26, pages 3688-3698.
Crossref
Crossref
Frank X. Guyette, Mazen Zenati, Darrell J. Triulzi, Mark H. Yazer, Hunter Skroczky, Barbara J. Early, Peter W. Adams, Joshua B. Brown, Louis Alarcon, Matthew D. Neal, Raquel M. Forsythe, Brian S. Zuckerbraun, Andrew B. Peitzman, Timothy R. Billiar & Jason L. Sperry. (2022) Prehospital low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial. Journal of Trauma and Acute Care Surgery 92:5, pages 839-847.
Crossref
Crossref
Jason B Brill, Brian Tang, Gabrielle Hatton, Krislynn M Mueck, C Cameron McCoy, Lillian S Kao & Bryan A Cotton. (2022) Impact of Incorporating Whole Blood into Hemorrhagic Shock Resuscitation: Analysis of 1,377 Consecutive Trauma Patients Receiving Emergency-Release Uncrossmatched Blood Products. Journal of the American College of Surgeons 234:4, pages 408-418.
Crossref
Crossref
Mark H. Yazer. (2021) The Evolution of Blood Product Use in Trauma Resuscitation: Change Has Come. Transfusion Medicine and Hemotherapy 48:6, pages 377-380.
Crossref
Crossref